Illumina Ventures

VC Foster City, United States · Founded 2016

Illumina Ventures is an independently managed venture capital firm focused on early-stage investments in genomics and precision health. The firm partners with pioneering entrepreneurs across life science tools, diagnostics, therapeutics, and digital health to transform human health.

About Illumina Ventures

Illumina Ventures is a strategic venture fund affiliated with Illumina, the genomics sequencing company, investing in early- and growth-stage life sciences and genomics-enabled companies including diagnostics, therapeutics development tools, AI for genomics, and clinical applications of sequencing. The fund operates with a degree of independence from Illumina’s balance sheet and writes checks generally in the $3M to $15M range across Series A through C, with the ability to lead or co-lead. Healthcare exposure is total and concentrated in genomics-adjacent life sciences. AI focus is meaningful, particularly in computational biology, variant interpretation, multi-omics, and drug discovery platforms that consume sequencing data. Founders best suited are technical CEOs in genomics, AI for biology, diagnostics, or precision oncology who would benefit from access to Illumina’s sequencing platforms, data, and commercial relationships with genomics centers and pharmaceutical companies. Founders who do not fit include digital health software targeting providers or payers without a genomics angle, therapeutics-only companies that do not consume Illumina technology, and consumer health businesses. Geographic preference is global, with concentrations in the US, Europe, and selectively Asia. The entry path is warm introduction through a portfolio CEO, an Illumina executive, or a top-tier life sciences co-investor. LinkedIn outreach to an investor with a specific genomics-aligned thesis is a reasonable secondary path. Expect deep technical diligence and a strategic partner that can be both an investor and a commercial enabler.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Team

Nick Naclerio, Ph.D.
Founding Partner
Abhijit u201cRonu201d Mazumder, Ph.D.
Partner
Wouter Meuleman, Ph.D.
Partner
Mara Aspinall
Partner
Martin Moorhead, Ph.D.
Chief AI Scientist
Malek Faham, M.D., Ph.D.
Chief Scientist

Pitch / review this investor

Have you raised from Illumina Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.